Epidemiological and genomic analyses identify drug classes associated with Lewy body dementia
Sonja W Scholz · 2025
Read Epidemiological and genomic analyses identify drug classes associated with Lewy body dementia by Sonja W Scholz (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715368.txt.
Description
Sonja Scholz reports a 2025 study hunting for drug links to Lewy body dementia, the second most common dementia of its kind after Alzheimer's disease. The condition is poorly understood, and no treatment yet changes its course. A fresh lead could come from drugs already in wide use for other illnesses.
The study compared a large group of United States Medicare patients with the disease against matched controls without it. It tested links between disease risk and more than a thousand prescribed drugs. Gene data were then used to probe whether heart-related traits play a causal role. Some drug classes stood out with higher or lower risk. Such signals can point researchers toward treatments worth testing properly in trials.
Catalog record
| CREATOR | Sonja W Scholz |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |